Webinar – The QuantideX® qPCR BCR-ABL IS Kit: A BCR-ABL Monitoring System that Meets and Exceeds Clinical Expectations for Testing
Clinical expectations for BCR-ABL monitoring have evolved over time both in response to more sensitive tests being developed and new treatments and management approaches emerging. Largely in response to these medical advances, many [...]
How the QuantideX® qPCR BCR-ABL IS Kit Provides a Simple, Sensitive, and Scalable BCR-ABL Monitoring Solution for a Laboratory
To mark the launch of the ground-breaking Quantidex® QPCR BCR-ABL IS Kit, manufacturer Asuragen held a series of three webinars. We covered the first two webinars here and here, so head there [...]
Analytical Validation of a BCR-ABL1 Monitoring System that Surpasses Current Testing Requirements
To mark the launch of the ground-breaking Quantidex® QPCR BCR-ABL IS Kit, manufacturer Asuragen held a series of three webinars. We covered the first webinar here, so check that out first if [...]
The Evolution of CML Patient Care and the Promise of Treatment-Free Remission – Webinar
To mark the launch of the Quantidex® QPCR BCR-ABL IS Kit, manufacturer Asuragen held a series of three webinars that examine the evolving clinical landscape around CML, as well as the history [...]
Best-in-class solution for assessment of major and minor BCR-ABL fusion transcripts
The success and effectiveness of Tyrosine Kinase Inhibitors (TKIs) for treatment of Chronic Myeloid Leukaemia (CML) has altered clinical expectations as patients live longer, healthier lives. This success has, in itself, created [...]
Achieving an international scale for standardising and interpreting molecular response in Chronic Myeloid Leukaemia patients
Advanced technology from Asuragen enables labs to reliably monitor leukaemia patients’ response to TKI therapy by reporting data on the international scale, ensuring effective CML treatment Chronic Myeloid Leukaemia (CML) affects 1.2 [...]
NewsAlison Wortley2025-04-15T10:47:42+00:00
